Intratumoral perforation following endoscopic duodenal stent placement for pancreatic cancer with gastric outlet obstruction.
Malignant gastric outlet obstruction is a common complication of advanced pancreatic cancer, leading to severe digestive symptoms and reduced quality of life.
APA
Takahashi H, Satoh T, et al. (2026). Intratumoral perforation following endoscopic duodenal stent placement for pancreatic cancer with gastric outlet obstruction.. Clinical journal of gastroenterology. https://doi.org/10.1007/s12328-026-02311-6
MLA
Takahashi H, et al.. "Intratumoral perforation following endoscopic duodenal stent placement for pancreatic cancer with gastric outlet obstruction.." Clinical journal of gastroenterology, 2026.
PMID
41870700
Abstract
Malignant gastric outlet obstruction is a common complication of advanced pancreatic cancer, leading to severe digestive symptoms and reduced quality of life. Endoscopic duodenal stent placement is a widely used palliative treatment; however, life-threatening complications, such as perforation, may occur. We present a case of a 74-year-old man with pancreatic cancer who developed intratumoral perforation following endoscopic duodenal stent placement for malignant gastric outlet obstruction. Imaging revealed tumor progression with necrosis and vascular involvement. This case highlights the need for careful risk assessment before duodenal stent placement, particularly in patients with tumor necrosis and ischemic risk.
같은 제1저자의 인용 많은 논문 (5)
- Real-World Comparative Study of Apalutamide Versus Bicalutamide in Combination With Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer.
- Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 study.
- Scrotal uptake on PSMA PET in prostate cancer: differentiating metastases from benign and physiologic findings using ultrasound correlation.
- Efficacy of CD19 CAR T-cell therapy in active vitreoretinal lymphoma.
- Neoadjuvant Chemotherapy for Initially Resectable Metachronous Colorectal Cancer Liver Metastases Is Associated With Early Postoperative Relapse.